RPR121056 (APC) is a major metabolite of Irinotecan (CPT-11) generated by the action of CYP3A4. Irinotecan (CPT-11) is an antineoplastic agent that inhibits topoisomerase type I, causing cell death, and is widely used in the treatment of colorectal cancer. Irinotecan also directly inhibits AChE.

纯度：≥98%

CAS：181467-56-1